Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Core EBITDA Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -3.593.8626.35-4.601.38

What is the latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH ?

The latest Core EBITDA Growth ratio of MEDICAMEN BIOTECH is -3.59 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-3.59
Mar20233.86
Mar202226.35
Mar2021-4.60
Mar20201.38

How is Core EBITDA Growth of MEDICAMEN BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2024 -3.59
Negative
Mar2023 3.86
-85.35
Mar2022 26.35
Positive
Mar2021 -4.6
Negative
Mar2020 1.38 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare Core EBITDA Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹518.2 Cr -4.2% -5.1% -10.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,607.0 Cr -5.9% -2.8% -5.3% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -3.7% -6.9% 30.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,471.0 Cr -3.8% 7.1% 12% Stock Analytics
CIPLA ₹121,103.0 Cr -3.9% -0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -6% -7.3% -12% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-4.2%

-5.1%

-10.7%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses